Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|July 5, 2011
Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patientsSaeed Al-Shieban, Elizabeth Byrne, Pritesh Trivedi, et al.
British Journal of Haematology|August 30, 2002
Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemiaRosa Ruchlemer, Andrew C Wotherspoon, Jeremy N Thompson, et al.
Haematologica|October 13, 2005
The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53Nnenna C Osuji, Ilaria Del Giudice, Estella Matutes, et al.
The American Journal of Pathology|January 28, 2003
Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutationsAnne Tierens, Jan Delabie, Agnieszka Malecka, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
MTHFR polymorphisms and risk of chronic lymphocytic leukemiaMatthew F Rudd, Gabrielle S Sellick, Ruth Allinson, et al.
Leukemia Research|May 15, 2002
CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual diseaseMariano P Scolnik, Ricardo Morilla, María Marta de E de Bracco, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2004
The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemiaGabrielle S Sellick, Matthew Rudd, Paul Eve, et al.
British Journal of Haematology|March 5, 2003
Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patientsNilima Parry-Jones, Estella Matutes, Alicja M Gruszka-Westwood, et al.
Haematologica|May 15, 2003
Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2AManal O Elnenaei, Alicja M Gruszka-Westwood, Roger A'Hernt, et al.
British Journal of Haematology|April 17, 2004
B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemiaRosa Ruchlemer, Nilima Parry-Jones, Vasantha Brito-Babapulle, et al.
Pageof 11